Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH

BACKGROUND: Nonalcoholic steatohepatitis (NASH) is considered to be part of the nonalcoholic fatty liver disorders and its incidence is increasing. Imm124-E (Immuron Ltd, Melbourne, Australia), containing hyperimmune bovine colostrum, has been shown to exert an immunomodulatory effect and to allevia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mizrahi, Meir, Shabat, Yehudit, Ben Ya’acov, Ami, Lalazar, Gadi, Adar, Tomer, Wong, Victor, Muller, Brian, Rawlin, Grant, Ilan, Yaron
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2012
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3534391/
https://ncbi.nlm.nih.gov/pubmed/23293533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JIR.S35227
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados